prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol)

For prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol), schedule is Schedule III; listed under is Anabolic steroids; cfr citation is 21 CFR 1308.13(f)(79), recorded from its source on 2026-09-01.

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

What the source says

(79) prostanozol (17β-hydroxy-5α-androstano[3,2-c]pyrazole or [3,2-c]pyrazole-5α-androstan-17β-ol);

— ecfr.gov, retrieved 2026-09-01

Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

— all from ecfr.gov, retrieved 2026-09-01

Source

• ecfr.govhttps://www.ecfr.gov/current/title-21/chapter-II/part-1308

Last verified against source: 2026-09-01. Due for re-check by 2026-12-30. This page as Markdown · OKF bundle · full dataset as JSON.